European cardiology 2000-2002SIMOONS, M. L.European heart journal. 2001, Vol 22, Num 1, pp 1-3, issn 0195-668XArticle

Interpretation of trials with drugs and devices ; a double standard ?SIMOONS, M. L.European heart journal. 1996, Vol 17, Num 10, pp 1463-1465, issn 0195-668XArticle

Integrating GP IIb/IIIa inhibitors in the management of acute coronary syndromesSIMOONS, M. L.European heart journal supplements. 2000, Vol 2, Num C, pp 22-25, issn 1520-765XConference Paper

Prevention and management of thrombotic complications during coronary interventions. MeetingSIMOONS, M. L; TIMMIS, A.European heart journal. 1995, Vol 16, Num NOV, issn 0195-668X, 111 p., SUPLConference Proceedings

Reperfusion strategies in acute myocardial infarctionBOERSMA, E; SIMOONS, M. L.European heart journal. 1997, Vol 18, Num 11, pp 1703-1711, issn 0195-668XArticle

Costs and effects of c7E3 in high risk PTCA patients : an indirect analysis for the NetherlandsVAN HOUT, B. A; SIMOONS, M. L.European heart journal. 1995, Vol 16, Num NOV, pp 81-85, issn 0195-668X, SUPLConference Paper

Tailored thrombolytic therapy : a perspectiveSIMOONS, M. L; ARNOLD, A. E. R.Circulation (New York, N.Y.). 1993, Vol 88, Num 6, pp 2556-2564, issn 0009-7322Article

Cost-effectiveness of HMG coenzyme reductase inhibitors: Whom to treat?VAN HOUT, B. A; SIMOONS, M. L.European heart journal. 2001, Vol 22, Num 9, pp 751-761, issn 0195-668XArticle

'Expected infarct size without thrombolysis', a concept that predicts immediate and long-term benefit from thrombolysis for evolving myocardial infarctionARNOLD, A. E. R; SIMOONS, M. L.European heart journal. 1997, Vol 18, Num 11, pp 1736-1748, issn 0195-668XArticle

Description of patients undergoing high risk angioplasty : analyses of various databasesKLEIMAN, N. S.European heart journal. 1995, Vol 16, Num NOV, pp 30-35, issn 0195-668X, SUPLConference Paper

Optimizing treatment of acute coronary syndromes with GP IIb/IIIa inhibitors: Proceedings of the satellite symposium to the XXIst Congress of the European Society of Cardiology, Barcelona, Spain, August 1999SIMOONS, M. L; HARRINGTON, R. A.European heart journal supplements. 2000, Vol 2, Num C, issn 1520-765X, 27 p.Conference Proceedings

Use of GP IIb/IIIa inhibitors in coronary syndromes: state of the art. International roundtableCALIFF, R. M; SIMOONS, M. L.European heart journal. 1998, Vol 19, Num AVR, issn 0195-668X, 68 p., SUPDConference Proceedings

Acute coronary thrombosis : the role of plaque disruption and its initiation and preventionDAVIES, M. J.European heart journal. 1995, Vol 16, Num NOV, pp 3-7, issn 0195-668X, SUPLConference Paper

The role of platelets in arterial thrombosis and the rationale for blockade of platelet GPIIb/IIIa receptors as antithrombotic therapyCOLLER, B. S.European heart journal. 1995, Vol 16, Num NOV, pp 11-15, issn 0195-668X, SUPLConference Paper

Clinical management of unstable angina : the place of antithrombins and platelet GP IIb/IIIa receptor blockersKNUDTSON, M. L.European heart journal. 1995, Vol 16, Num NOV, pp 68-74, issn 0195-668X, SUPLConference Paper

Costs and effects in therapy for acute coronary syndromes : The case of abciximab in high-risk patients undergoing percutaneous transluminal coronary angioplasty in the EPIC studyVAN HOUT, B. A; BOWMAN, L; ZELINGER, D. J et al.European heart journal. 1998, Vol 19, Num AVR, pp D59-D66, issn 0195-668X, SUPDConference Paper

Prevention and management of thrombotic complications during coronary interventions : combination therapy with antithrombins, antiplatelets, and/or thrombolytics : risks and benefitsNEUHAUS, K.-L; ZEYMER, U.European heart journal. 1995, Vol 16, Num NOV, pp 63-67, issn 0195-668X, SUPLConference Paper

Managing chest pain in the emergency roomBROGAN, G. X.European heart journal supplements. 2000, Vol 2, Num C, pp 15-21, issn 1520-765XConference Paper

A review of the long term effects of thrombolytic agentsVAN DOMBURG, R. T; BOERSMA, E; SIMOONS, M. L et al.Drugs (Basel). 2000, Vol 60, Num 2, pp 293-305, issn 0012-6667Article

The Rationale and Design of the Perindopril Genetic Association Study (PERGENE) : A Pharmacogenetic Analysis of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients with Stable Coronary Artery DiseaseBRUGTS, J. J; DE MAAT, M. P. M; DANSER, A. H. J et al.Cardiovascular drugs and therapy. 2009, Vol 23, Num 2, pp 171-181, issn 0920-3206, 11 p.Article

ACE inhibition and endothelial function : Main findings of PERFECT, a sub-study of the EUROPA trialBOTS, M. L; REMME, W. J; LIISCHER, T. F et al.Cardiovascular drugs and therapy. 2007, Vol 21, Num 4, pp 269-279, issn 0920-3206, 11 p.Article

Excellent survival and low incidence of arrhythmias, stroke and heart failure long-term after surgical ASD closure at young age: A prospective follow-up study of 21-33 yearsROOS-HESSELINK, J. W; MEIJBOOM, F. J; SPITAELS, S. E. C et al.European heart journal. 2003, Vol 24, Num 2, pp 190-197, issn 0195-668X, 8 p.Article

Predictive value of C-reactive protein and Troponin T in patients with Unstable angina : A comparative analysisHEESCHEN, C; HAMM, C. W; BRUEMMER, J et al.Journal of the American College of Cardiology. 2000, Vol 35, Num 6, pp 1535-1542, issn 0735-1097Article

The benefit of Abciximab in percutaneous coronary revascularization is not device-specificBHATT, D. L; LINCOFF, A. M; CALIFF, R. M et al.The American journal of cardiology. 2000, Vol 85, Num 9, pp 1060-1064, issn 0002-9149Article

Association between minor elevations of creatine kinase-MB level and Mortality in patients with acute coronary syndromes without ST-segment elevationALEXANDER, J. H; SPARAPANI, R. A; CALIFF, R. M et al.JAMA, the journal of the American Medical Association. 2000, Vol 283, Num 3, pp 347-353, issn 0098-7484Article